Ole Schjerning

Middelfart, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Ethnic disparities in rapid tranquillisation use and explanations in adult mental health emergency settings? A systematic review.

Ethnic disparities in rapid tranquillisation use and explanations in adult mental health emergency settings? A systematic review.

Journal: General hospital psychiatry

Published: February 04, 2025

Ethnic disparities in rapid tranquillisation use and justifications in adult mental health inpatient settings: a systematic review and meta-analysis.

Ethnic disparities in rapid tranquillisation use and justifications in adult mental health inpatient settings: a systematic review and meta-analysis.

Journal: BMJ mental health

Published: October 11, 2024

High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine.

High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine.

Journal: CNS spectrums

Published: January 01, 2019

One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.

One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.

Journal: Acta psychiatrica Scandinavica

Published: October 25, 2018

Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up.

Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up.

Journal: International journal of bipolar disorders

Published: October 11, 2018

Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.

Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.

Journal: Schizophrenia research

Published: August 05, 2017

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: June 12, 2017

Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review.

Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review.

Journal: Journal of psychopharmacology (Oxford, England)

Published: March 29, 2017

Antipsychotic-associated psoriatic rash - a case report.

Antipsychotic-associated psoriatic rash - a case report.

Journal: BMC psychiatry

Published: January 09, 2017

Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.

Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.

Journal: International journal of clinical practice

Published: July 29, 2016

Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential.

Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential.

Journal: Pharmacopsychiatry

Published: March 09, 2016

Cardiovascular safety of antipsychotics: a clinical overview.

Cardiovascular safety of antipsychotics: a clinical overview.

Journal: Expert opinion on drug safety

Published: March 03, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026